These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

406 related articles for article (PubMed ID: 24799414)

  • 1. Monofunctional platinum(II) complexes with potent tumor cell growth inhibitory activity: the effect of a hydrogen-bond donor/acceptor N-heterocyclic ligand.
    Margiotta N; Savino S; Gandin V; Marzano C; Natile G
    ChemMedChem; 2014 Jun; 9(6):1161-8. PubMed ID: 24799414
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Sterically hindered complexes of platinum(II) with planar heterocyclic nitrogen donors. A novel complex with 1-methyl-cytosine has a spectrum of activity different from cisplatin and is able of overcoming acquired cisplatin resistance.
    Margiotta N; Natile G; Capitelli F; Fanizzi FP; Boccarelli A; De Rinaldis P; Giordano D; Coluccia M
    J Inorg Biochem; 2006 Nov; 100(11):1849-57. PubMed ID: 16959321
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Synthesis, cytotoxic activity and DNA interaction studies of new dinuclear platinum(ii) complexes with an aromatic 1,5-naphthyridine bridging ligand: DNA binding mode of polynuclear platinum(ii) complexes in relation to the complex structure.
    Konovalov B; Živković MD; Milovanović JZ; Djordjević DB; Arsenijević AN; Vasić IR; Janjić GV; Franich A; Manojlović D; Skrivanj S; Milovanović MZ; Djuran MI; Rajković S
    Dalton Trans; 2018 Oct; 47(42):15091-15102. PubMed ID: 30303498
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Anti-cancer characteristics and ototoxicity of platinum(II) amine complexes with only one leaving ligand.
    Monroe JD; Hruska HL; Ruggles HK; Williams KM; Smith ME
    PLoS One; 2018; 13(3):e0192505. PubMed ID: 29513752
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Synthesis, characterization, and biological evaluation of new tetrazole-based platinum(II) and palladium(II) chlorido complexes--potent cisplatin analogues and their trans isomers.
    Serebryanskaya TV; Yung T; Bogdanov AA; Shchebet A; Johnsen SA; Lyakhov AS; Ivashkevich LS; Ibrahimava ZA; Garbuzenco TS; Kolesnikova TS; Melnova NI; Gaponik PN; Ivashkevich OA
    J Inorg Biochem; 2013 Mar; 120():44-53. PubMed ID: 23305964
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effect of thioethers on DNA platination by trans-platinum complexes.
    Li C; Huang R; Ding Y; Sletten E; Arnesano F; Losacco M; Natile G; Liu Y
    Inorg Chem; 2011 Sep; 50(17):8168-76. PubMed ID: 21812429
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Mixed natural arylolefin-quinoline platinum(II) complexes: synthesis, structural characterization and in vitro cytotoxicity studies.
    Chi NTT; Thong PV; Mai TTC; Van Meervelt L
    Acta Crystallogr C Struct Chem; 2018 Dec; 74(Pt 12):1732-1743. PubMed ID: 30516159
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Novel methylene modified cyclohexyl ethylenediamine-N,N'-diacetate ligands and their platinum(IV) complexes. Influence on biological activity.
    Mihajlović LE; Savić A; Poljarević J; Vučković I; Mojić M; Bulatović M; Maksimović-Ivanić D; Mijatović S; Kaluđerović GN; Stošić-Grujičić S; Miljković Đ; Grgurić-Šipka S; Sabo TJ
    J Inorg Biochem; 2012 Apr; 109():40-8. PubMed ID: 22369771
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Synthesis, Characterization, and Cytotoxicity Evaluation of Novel Water-Soluble Cationic Platinum(II) Organometallic Complexes with Phenanthroline and Imidazolic Ligands.
    Ali A; Stefàno E; De Castro F; Ciccarella G; Rovito G; Marsigliante S; Muscella A; Benedetti M; Fanizzi FP
    Chemistry; 2024 Jul; 30(38):e202401064. PubMed ID: 38703115
    [TBL] [Abstract][Full Text] [Related]  

  • 10. trans,cis,cis-bis(benzoato)dichlorido(cyclohexane-1R,2R-diamine)platinum(IV): a prodrug candidate for the treatment of oxaliplatin-refractory colorectal cancer.
    Gandin V; Marzano C; Pelosi G; Ravera M; Gabano E; Osella D
    ChemMedChem; 2014 Jun; 9(6):1299-305. PubMed ID: 24715720
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Oxaliplatin derived monofunctional triazole-containing platinum(II) complex counteracts oxaliplatin-induced drug resistance in colorectal cancer.
    Li Y; Sun Z; Cui Y; Zhang H; Zhang S; Wang X; Liu S; Gao Q
    Bioorg Chem; 2021 Feb; 107():104636. PubMed ID: 33465670
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Synthesis of antitumor azolato-bridged dinuclear platinum(ii) complexes with in vivo antitumor efficacy and unique in vitro cytotoxicity profiles.
    Komeda S; Takayama H; Suzuki T; Odani A; Yamori T; Chikuma M
    Metallomics; 2013 May; 5(5):461-8. PubMed ID: 23608770
    [TBL] [Abstract][Full Text] [Related]  

  • 13. DNA cleavage and antitumour activity of platinum(II) and copper(II) compounds derived from 4-methyl-2-N-(2-pyridylmethyl)aminophenol: spectroscopic, electrochemical and biological investigation.
    Roy S; Maheswari PU; Lutz M; Spek AL; den Dulk H; Barends S; van Wezel GP; Hartl F; Reedijk J
    Dalton Trans; 2009 Dec; (48):10846-60. PubMed ID: 20023915
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Quinoxaline-2-carboxamide as a carrier ligand in two new platinum(II) compounds: Synthesis, crystal structure, cytotoxic activity and DNA interaction.
    Marqués-Gallego P; Gamiz-Gonzalez MA; Fortea-Pérez FR; Lutz M; Spek AL; Pevec A; Kozlevčar B; Reedijk J
    Dalton Trans; 2010 Jun; 39(21):5152-8. PubMed ID: 20419195
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Platinum(II) carboxylato complexes containing 7-azaindoles as N-donor carrier ligands showed cytotoxicity against cancer cell lines.
    Štarha P; Trávníček Z; Pazderová L; Dvořák Z
    J Inorg Biochem; 2016 Sep; 162():109-116. PubMed ID: 27350081
    [TBL] [Abstract][Full Text] [Related]  

  • 16. DNA binding mode of the cis and trans geometries of new antitumor nonclassical platinum complexes containing piperidine, piperazine, or 4-picoline ligand in cell-free media. Relations to their activity in cancer cell lines.
    Kasparkova J; Marini V; Najajreh Y; Gibson D; Brabec V
    Biochemistry; 2003 May; 42(20):6321-32. PubMed ID: 12755637
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Synthesis, characterization, in vitro antitumoral investigations and interaction with plasmid pBR322 DNA of R2eddp-platinum(IV) complexes (R = Et, n-Pr).
    Kaluderović GN; Kommera H; Schwieger S; Paethanom A; Kunze M; Schmidt H; Paschke R; Steinborn D
    Dalton Trans; 2009 Dec; (48):10720-6. PubMed ID: 20023900
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Palladium(II) and platinum(II) organometallic complexes with 4,7-dihydro-5-methyl-7-oxo[1,2,4]triazolo[1,5-a]pyrimidine. Antitumor activity of the platinum compounds.
    Ruiz J; Villa MD; Cutillas N; López G; de Haro C; Bautista D; Moreno V; Valencia L
    Inorg Chem; 2008 Jun; 47(11):4490-505. PubMed ID: 18447329
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Modulation of drug activation profiles through carboxylate ligand modification in cytotoxic trans-platinum planar amine compounds.
    Benedetti BT; Quintal S; Farrell NP
    Dalton Trans; 2011 Nov; 40(41):10983-8. PubMed ID: 21918760
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The influence of the ethane-1,2-diamine ligand on the activity of a monofunctional platinum complex.
    Graziotto ME; Akerfeldt MC; Gunn AP; Yang K; Somerville MV; Coleman NV; Roberts BR; Hambley TW; New EJ
    J Inorg Biochem; 2017 Dec; 177():328-334. PubMed ID: 28789807
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 21.